Lux-Lantos Victoria A, Bianchi María S, Catalano Paolo N, Libertun Carlos
Laboratory of Neuroendocrinology, Instituto de Biología y Medicina Experimental-CONICET, V. de Obligado 2490, C1428ADN, Buenos Aires, Argentina.
Cell Mol Neurobiol. 2008 Sep;28(6):803-17. doi: 10.1007/s10571-008-9263-4. Epub 2008 Feb 9.
Gamma-amino butyric acid (GABA), in addition to being a metabolic intermediate and the main inhibitory neurotransmitter in the synaptic cleft, is postulated as a neurohormone, a paracrine signaling molecule, and a trophic factor. It acts through pre- and post-synaptic receptors, named GABA(A) and GABA(C) (ionotropic receptors) and GABA(B) (metabotropic receptor). Here we reviewed the participation of GABA(B) receptors in the regulation of the hypothalamic-pituitary-gonadal axis, using physiological, biochemical, and pharmacological approaches in rats, as well as in GABA(B1) knock-out mice, that lack functional GABA(B) receptors. Our general conclusion indicates that GABA(B )receptors participate in the regulation of pituitary hormone secretion acting both in the central nervous system and directly on the gland. PRL and gonadotropin axes are affected by GABA(B) receptor activation, as demonstrated in the rat and also in the GABA(B1) knock-out mouse. In addition, hypothalamic and pituitary GABA(B) receptor expression is modulated by steroid hormones. GABA participation in the brain control of pituitary secretion through GABA(B) receptors depends on physiological conditions, being age and sex critical factors.These results indicate that patients receiving GABA(B) agonists/antagonists should be monitored for possible endocrine side effects.
γ-氨基丁酸(GABA),除了作为一种代谢中间产物以及突触间隙中的主要抑制性神经递质外,还被假定为一种神经激素、旁分泌信号分子和营养因子。它通过突触前和突触后受体发挥作用,这些受体分别被命名为GABA(A)和GABA(C)(离子型受体)以及GABA(B)(代谢型受体)。在此,我们利用生理学、生物化学和药理学方法,对大鼠以及缺乏功能性GABA(B)受体的GABA(B1)基因敲除小鼠进行研究,回顾了GABA(B)受体在下丘脑-垂体-性腺轴调节中的作用。我们的总体结论表明,GABA(B)受体参与垂体激素分泌的调节,其作用途径包括在中枢神经系统中发挥作用以及直接作用于腺体。催乳素(PRL)和促性腺激素轴会受到GABA(B)受体激活的影响,这在大鼠以及GABA(B1)基因敲除小鼠中均得到证实。此外,下丘脑和垂体中GABA(B)受体的表达会受到甾体激素的调节。GABA通过GABA(B)受体参与对垂体分泌的脑内调控取决于生理状况,年龄和性别是关键因素。这些结果表明,对于接受GABA(B)激动剂/拮抗剂治疗的患者,应监测其可能出现的内分泌副作用。